Company Filing History:
2 out of 2 
2 out of 3 
2 out of 35 
Years Active: 1996-1998
Title: Inventor Charles James Dorman: A Pioneer in Live Vaccines
Introduction
Charles James Dorman, based in Dundee, GB, is a prominent inventor known for his contributions to the field of vaccine development. With a portfolio of two patents, Dorman's innovative work focuses on attenuating bacteria for use as live vaccines, significantly impacting human and animal medicine.
Latest Patents
His latest inventions include a novel approach to creating live vaccines by attenuating bacteria. The first patent outlines a method for mutating a gene responsible for regulating the expression of outer membrane proteins, particularly porin proteins. This method provides a framework for developing vaccines that can effectively fight off infections. The second patent focuses specifically on attenuated Salmonella, utilizing a similar gene mutation strategy to create effective live vaccines for both human and animal medicine.
Career Highlights
Throughout his career, Charles James Dorman has worked with esteemed organizations such as The Royal Society and The Lister Institute of Preventive Medicine. His research and innovations have played a crucial role in advancing the understanding and application of vaccine technology.
Collaborations
Dorman has collaborated with notable scientists like Gordan Dougan and Steven Neville Chatfield. These partnerships have further enhanced his research efforts, leading to significant advancements in the field of microbiology and vaccine development.
Conclusion
Charles James Dorman stands out as a significant figure in the realm of vaccine invention. His patents addressing the attenuation of bacteria have opened new avenues for healthcare solutions. Through his innovative spirit and collaborative efforts, Dorman continues to influence the future of medicine.